Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor

Neuroscience

Volumn 125, Issue 4, 2004, Pages 853-859

  Chen, L ^a   Yung, K K L ^b   Yung, W H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

( ) 2 amino 5 phosphonopentanoic acid; (2S) 3 (1S) 1 (3,4 dichlorophenyl)ethyl amino 2 hydroxylpropyl , (phenylmethyl)phosphinic acid; ACSF; AP5; artificial cerebrospinal fluid; CGP55845; CNQX; globus pallidus; neurotensin; SR142948A; SR48692

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA ETHYL 4 CARBOXYPHENYLGLYCINE; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; BICUCULLINE; E4CPG; IONOTROPIC RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; NEUROTENSIN; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; NEUROTENSIN TYPE 1 RECEPTOR; NEUROTENSIN TYPE 1 RECEPTOR ANTAGONIST; NEUROTENSIN TYPE 2 RECEPTOR ANTAGONIST; NEUROTENSIN[1-8]; NEUROTENSIN[8-13]; TETRODOTOXIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG SELECTIVITY; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PATCH CLAMP; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ADAMANTANE; ANESTHETICS, LOCAL; ANIMALS; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; IMIDAZOLES; NEURONS; NEUROTENSIN; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PYRAZOLES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 2142715913     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.02.031     Document Type: Article

References (43)

1. Atoji Y., Watanabe H., Yamamoto Y., Suzuki Y. Distribution of neurotensin-containing neurons in the central nervous system of the dog. J Comp Neurol. 353:1995;67-88
2. Audinat E., Hermel J.M., Crepel F. Neurotensin induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro. Exp Brain Res. 78:1989;358-368
3. Bergstrom D.A., Walters J.R. Dopamine attenuates the effects of GABA on single unit activity in the globus pallidus. Brain Res. 310:1984;23-33
4. Boireau A., Miquet J.M., Olivier V. Neurotensin modulates differently potassium, veratridine and 4-aminopyridine-evoked release of dopamine in rat striatal slices. Fund Clin Pharmacol. 7:1993;109-114
5. Bolam J.P., Hanley J.J., Booth P.A.C., Bevan M.D. Synaptic organisation of the basal ganglia. J Anat. 196:2000;527-542
6. Boules M., Warrington L., Fauq A., McCormick D., Richelson E. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. Eur J Pharmacol. 428:2001;227-233
7. Brog J.S., Zahm D.S. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus. Neuroscience. 74:1996;805-812
8. 3H] neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections Evidence from a receptor autoradiographic study. Brain Res. 564:1991;37-44
9. Carraway R., Leeman S.E. Characterization of radioimmuno-assayable neurotensin in the rat Its differential distribution in the central nervous system, small intestine and stomach. J Biol Chem. 251:1976;7045-7052
10. Chinaglia G., Probst A., Palacios J.M. Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy An autoradiographic study in basal ganglia. Neuroscience. 39:1990;351-360
11. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders An update. Trends Neurosci. 19:1996;417-422
12. Cooper A.J., Stanford I.M. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology. 41:2001;62-71
13. Fassio A., Evans G., Grisshammer R., Bolam J.P., Mimmack M., Emson P.C. Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology. 39:2000;1430-1442
14. Fernandez A., de Ceballos M.L., Jenner P., Marsden C.D. Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. Neuroscience. 61:1994;73-79
15. Fernandez A., Jenner P., Marsden C.D., De Ceballos M.L. Characterization of neurotensin-like immunoreactivity in human basal ganglia Increased neurotensin levels in substantia nigra in parkinson's disease. Peptides. 16:1995;339-346
16. Ferraro L., O'Connor W.T., Antonelli T., Fuxe K., Tanganelli S. Differential effects of intrastriatal neurotensin (1-13) and neurotensin (8-13) on striatal dopamine and pallidal GABA release A dual-probe microdialysis study in the awake rat. Eur J Neurosci. 9:1997;1838-1846
17. Ferraro L., Tomasini M.C., Siniscalchi A., Fuxe K., Tanganelli S., Antonelli T. Neurotensin increases endogenous glutamate release in rat cortical slices. Life Sci. 66:2000;927-936
18. Ferraro L., Tomasini M.C., Fernandez M., Bebe B.W., O'Connor W.T., Fuxe K., Glennon J.C., Tanganelli S., Antonelli T. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission A dual-probe microdialysis study in intact conscious rat brain. Neuroscience. 102:2001;113-120
19. Hanson G.R., Keefe K.A. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Brain Res Mol Brain Res. 66:1999;111-121
20. Hetier E., Boireau A., Dubedat P., Blanchard J.C. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat. Naunyn Schmiedebergs Arch Pharmacol. 337:1988;13-17
21. Hokfelt T., Broberger C., Xu Z.Q.D., Sergeyev V., Ubink R., Diez M. Neuropeptides An overview. Neuropharmacology. 39:2000;1337-1356
22. Jiang Z.G., Pessia M., North R.A. Neurotensin excitation of rat ventral tegmental neurons. J Physiol. 474:1994;119-129
23. Kasckow J., Nemeroff C.B. The neurobiology of neurotensin Focus on neurotensin-dopamine interactions. Regul Pept. 36:1991;153-164
24. Kinkead B., Binder E.B., Nemeroff C.B. Does neurotensin mediate the effects of antipsychotic drugs? Biol Psychiatry. 46:1999;340-351
25. Kirkpatrick K., Bourque C.W. Effects of neurotensin on rat supraoptic nucleus neurones in vitro. J Physiol. 482:1995;373-381
26. Le F., Cusack B., Richelson E. The neurotensin receptor Is there more than one subtype? Trends Pharmacol Sci. 17:1996;1-3
27. Legault M., Congar P., Michel F.J., Trudeau L.-E. Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones. Neuroscience. 111:2002;177-187
28. Li A.H., Hwang H.M., Tan P.P., Wu T., Wang H.L. Neurotensin excites periaqueductal gray neurons projecting to the rostral ventromedial medulla. J Neurophysiol. 85:2001;1479-1488
29. Matthews R.T. Neurotensin depolarizes cholinergic and a subset of non-cholinergic septal/diagonal band neurons by stimulating neurotensin-1 receptors. Neuroscience. 94:1999;775-783
30. McCormick S.E., Stoessl A.J. Central administration of the neurotensin receptor antagonist SR48692 attentuates vacuous chewing movements in a rodent model of tardive dyskinesia. Neuroscience. 119:2003;547-555
31. Mouroux M., Hassani O.K., Feger J. Electrophysiological and Fos immunohistochemical evidence for the excitatory nature of the parafascicular projection to the globus pallidus. Neuroscience. 81:1997;387-397
32. Naito A., Kita H. The cortico-pallidal projection in the rat An anterograde tracing study with biotinylated dextran amine. Brain Res. 653:1994;251-257
33. Nakanishi H., Hori N., Kastuda N. Neostriatal evoked inhibition and effects of dopamine on globus pallidal neurons in rat slice preparations. Brain Res. 358:1985;282-286
34. Nicot A., Rostene W., Berod A. Neurotensin receptor expression in the rat forebrain and midbrain A combined analysis by in situ hybridization and receptor autoradiography. J Comp Neurol. 341:1994;407-419
35. Palacios J.M., Kuhar M.J. Neurotensin receptors are located on dopamine-containing neurones in rat midbrain. Nature. 294:1981;587-589
36. Reyneke L., Russell V.A., Taljaard J.J. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation. Brain Res. 534:1990;188-194
37. Saleh T.M., Kombian S.B., Zidichouski J.A., Pittman Q.J. Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro. Neuroscience. 77:1997;23-35
38. Sarret P., Perron A., Stroh T., Beaudet A. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J Comp Neurol. 461:2003;520-538
39. Taylor M.D., De Ceballos M.L., Rose S., Jenner P., Marsden C.D. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3, 4- dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia. Eur J Pharmacol. 219:1992;183-192
40. Tyler-McMahon B.M., Boules M., Richelson E. Neurotensin Peptide for the next millennium. Regul Pept. 93:2000;125-136
41. Uhl G.R., Kuhar M.J. Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra. Nature. 309:1984;350-352
42. Vincent P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci. 20:1999;302-309
43. Zahm D.S., Johnson S.N. Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6-hydroxydopamine in rat ventral tegmental area (VTA). Brain Res. 483:1989;301-311